CellSource Co

CellSource Co Interest Coverage

The Interest Coverage Ratio of CellSource Co (4880.T) as of Oct 27, 2026 is 16.09. In the previous year, Interest Coverage Ratio was 3.39 — a change of 374.28% (higher).

Interest Coverage

16.09

YoY

374.28%

Last updated:

Interest Coverage Ratio of CellSource Co is 2025 16.09 . Interest Coverage Ratio of CellSource Co was 2024 3.39 . It decreases by 374.28% higher compared to the previous year.

The CellSource Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
337.25 JPY
Jan 1, 2019
944.92 JPY
Jan 1, 2020
220.22 JPY
Jan 1, 2021
152.67 JPY
Jan 1, 2022
89.96 JPY
Jan 1, 2023
54.95 JPY
Jan 1, 2024
3.39 JPY
Jan 1, 2025
16.09 JPY
The CellSource Co Interest Coverage history
YEARInterest CoverageYoY
16.09+374.28%
3.39-93.82%
54.95-38.92%
89.96-41.07%
152.67-30.67%
220.22-76.69%
944.92+180.19%
337.25-32.40%
498.92—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Interest Coverage Ratio of CellSource Co is 16.09 in 2025.

Interest Coverage Ratio of CellSource Co changed from 3.39 to 16.09, representing a 374.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio CellSource Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's CellSource Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — CellSource Co

All Key Metrics — CellSource Co